CPC Biocast
CPC Biocast
Podcast Description
CPC Biocast is a podcast focused on bioprocessing in the biopharma and cell & gene therapy industries designed to educate, discuss relevant topics with industry experts and to provide best practices.
Podcast Insights
Content Themes
The podcast centers on key themes such as bioprocessing innovations, modularity in manufacturing, and best practices in biopharma and cell & gene therapy. For instance, the pilot episode explores modularity, focusing on topics like the revolution of the single-use industry, the distinctions between 'Big-S' and 'Little-S' in standardization, and the implications of supply chain challenges for modular adoption.
CPC Biocast is a podcast focused on bioprocessing in the biopharma and cell & gene therapy industries designed to educate, discuss relevant topics with industry experts and to provide best practices.
Today’s episode focuses on new and upcoming regulations shaping process manufacturing – specifically, Annex I and USP665. To help us understand these regulations and standards, and the impacts associated with each, we brought in Single-Use Specialist, Kevin de Jager from Hitma, a single-use solutions company.
Hitma is a company with a mission to help customers reduce risk, save time and reduce costs by delivering the right bioprocess from discovery to fill-finish.
Episode 5 Outline:
- Part I: USP
- Part II: Annex 1
Hosted by Michael Francis, Sr. Product Manager.With special guest and single-use specialist – Kevin de Jager of Hitma
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.